Arbutus Biopharma Corp (ABUS)

May 02, 2025

Arbutus Biopharma Corp (ABUS) is a good investment, but the stock may be overvalued - uspostnews.com

May 02, 2025

May 01, 2025

Arbutus Biopharma Corp (ABUS) With A Potential Upside Of More Than -139.44% - Stocksregister

May 01, 2025

May 01, 2025

Arbutus Biopharma Corp (ABUS) looking to reclaim success with recent performance - Sete News

May 01, 2025

May 01, 2025

Legal & General Group Plc Has $388,000 Stock Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 01, 2025

Apr 30, 2025

Arbutus Biopharma Corp [ABUS] Insider Activity: An Update for Investors - knoxdaily.com

Apr 30, 2025

Apr 28, 2025

Arbutus Biopharma Corp expected to post a loss of 10 cents a shareEarnings Preview - TradingView

Apr 28, 2025

Apr 26, 2025

Stock Market Recap: Arbutus Biopharma Corp (ABUS) Concludes at 3.12, a -1.58 Surge/Decline - DWinneX

Apr 26, 2025

Apr 24, 2025

Will Arbutus Biopharma (ABUS) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance

Apr 24, 2025

Apr 24, 2025

Arbutus Biopharma Showcases Promising Hepatitis B Research at EASL Congress - MyChesCo

Apr 24, 2025

Apr 23, 2025

Arbutus Biopharma Corp (ABUS)’s stock price in review: A technical analysis - uspostnews.com

Apr 23, 2025

Apr 23, 2025

Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025 - GlobeNewswire

Apr 23, 2025

Apr 21, 2025

Alliancebernstein L.P. Has $393,000 Stock Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 21, 2025

Apr 19, 2025

Franklin Resources Inc. Takes $301,000 Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 19, 2025

Apr 15, 2025

Arbutus Biopharma Co. (NASDAQ:ABUS) Shares Purchased by Vanguard Group Inc. - Defense World

Apr 15, 2025

Apr 14, 2025

Raymond James Financial Inc. Takes $34,000 Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 14, 2025

Apr 13, 2025

Wellington Management Group LLP Buys 16,484 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 13, 2025

Apr 12, 2025

Corebridge Financial Inc. Has $238,000 Stock Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 12, 2025

Apr 11, 2025

KLP Kapitalforvaltning AS Invests $84,000 in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 11, 2025

Apr 03, 2025

Teacher Retirement System of Texas Raises Stock Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 03, 2025

Apr 02, 2025

Warminster-Based Arbutus Biopharma Lays Off Over Half of Workforce, Exits Its Headquarters - BUCKSCO.Today

Apr 02, 2025

Apr 01, 2025

Moderna (NasdaqGS:MRNA) Faces Legal Spotlight Affecting Investor Sentiment with -8% Dip Over Last Month - Yahoo Finance

Apr 01, 2025

Apr 01, 2025

Arbutus Biopharma Corp (NASDAQ: ABUS) – An Analysis Is What You Need - stocksregister.com

Apr 01, 2025

Mar 31, 2025

Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace

Mar 31, 2025

Mar 31, 2025

Is Arbutus Biopharma (ABUS) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Mar 31, 2025

Mar 31, 2025

ABUS’s Market Whiplash: 7.03% YTD Rise, 3.86% Rise in 30 Days - investchronicle.com

Mar 31, 2025

Mar 30, 2025

Arbutus Biopharma Reports 2024 Financial Results and Strategic Updates - MSN

Mar 30, 2025

Mar 30, 2025

Xponance Inc. Takes $34,000 Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Mar 30, 2025

Mar 30, 2025

Chardan Capital Reiterates “Buy” Rating for Arbutus Biopharma (NASDAQ:ABUS) - Defense World

Mar 30, 2025

Mar 29, 2025

Arbutus Biopharma (NASDAQ:ABUS) Trading 4.1% Higher Following Strong Earnings - Defense World

Mar 29, 2025

Mar 29, 2025

Arbutus Biopharma (NASDAQ:ABUS) Rating Increased to Hold at StockNews.com - Defense World

Mar 29, 2025

Mar 27, 2025

Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Mar 27, 2025

Mar 27, 2025

Arbutus Biopharma earnings beat by $0.02, revenue fell short of estimates - Investing.com

Mar 27, 2025

Mar 27, 2025

Arbutus stock gains after 57% workforce cuts (ABUS:NASDAQ) - Seeking Alpha

Mar 27, 2025

Mar 27, 2025

Was there any good news for Arbutus Biopharma Corp (ABUS) stock in the last session? - uspostnews.com

Mar 27, 2025

Mar 27, 2025

Arbutus Biopharma Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025

Mar 27, 2025

Arbutus Biopharma (ABUS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 27, 2025

Mar 27, 2025

Arbutus Biopharma Announces 2024 Financial Results and Strategic Restructuring - TipRanks

Mar 27, 2025

Mar 27, 2025

Charles Schwab Investment Management Inc. Acquires 9,955 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Mar 27, 2025

Mar 20, 2025

Arbutus Biopharma Co-Founder Dr. Michael Sofia to Retire After a Storied Career in Antiviral Drug Discovery - MSN

Mar 20, 2025

Mar 10, 2025

Reviewing Akari Therapeutics (NASDAQ:AKTX) and Arbutus Biopharma (NASDAQ:ABUS) - Defense World

Mar 10, 2025

Mar 09, 2025

Moderna (NasdaqGS:MRNA) Sees 15% Jump Despite Recent Revenue Challenges - Yahoo Finance

Mar 09, 2025

Mar 08, 2025

FY2025 Earnings Forecast for ABUS Issued By Chardan Capital - Defense World

Mar 08, 2025

Mar 07, 2025

Are Arbutus Biopharma Corp’shares a good deal? - US Post News

Mar 07, 2025

Mar 07, 2025

Moderna (NasdaqGS:MRNA) Rises 10% Despite US$1 Billion Revenue Drop Prediction - Yahoo Finance

Mar 07, 2025

Mar 04, 2025

Moderna Faces MRNA Vax Patent Suits In Canada And Beyond - Law360

Mar 04, 2025

Mar 03, 2025

Genevant Sciences and Arbutus Biopharma Initiate - GlobeNewswire

Mar 03, 2025

Mar 03, 2025

Genevant Sciences and Arbutus Biopharma File International Lawsuits Against Moderna for Patent Infringement of Lipid Nanoparticle Technology - Nasdaq

Mar 03, 2025

Mar 03, 2025

Can Arbutus Win Billions? Patent Fight Against Moderna's COVID Vaccine Goes Global - StockTitan

Mar 03, 2025

Feb 28, 2025

Arbutus Biopharma (NASDAQ:ABUS) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat

Feb 28, 2025